Search Results 31-40 of 11822 for lewy body dementia
... Lewy body dementia. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder · Overview · Participation eligibility.
Dementia with Lewy bodies (DLB) is part of Lewy body dementia, the 2nd-most-common degenerative dementia in the U.S. It is also one of the Alzheimer's ...
The purpose of this study is to examine the effects of the medication Armodafinil in patients who have dementia with Lewy bodies which is associated with ...
... Lewy body dementia, frontotemporal degeneration, mild cognitive impairment or a related disorder. Caring for Lewy. Caring for Lewy is an online education and ...
A Study of Change in Imaging Biomarkers of Dementia with Lewy Bodies (DLB) and Associations with Cognitive and Functional Decline · Overview · Participation ...
May your appreciation of the positive elements in your life, past and present, help you to cope with and even benefit from your experience of Dementia Lewy Body ...
Also, to test the hypothesis that prospective intervention with a DPP4 inhibitor or SGLT2 inhibitor improves Parkinson's disease and Lewy Body Dementia related ...
A Study of LY3154207 in Participants With Parkinson's Disease Dementia or Dementia with Lewy Bodies ... dementia treated for 12 weeks. Participation ...
This common dementia is caused by a buildup of proteins in the brain. It affects thinking, memory and movement.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.